Summary
The product Injectable Dbol 50mg, manufactured by Olympian Pharmaceutical, underwent independent testing to verify its authenticity and potency. The sample, identified by batch number 0069, was submitted by Olympian Pharmaceutical and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis detected the presence of Methandienone, with a measured concentration of 49.11 mg/ml, which is 1.78% below the labeled claim of 50 mg/ml.
The testing process began on 24 October 2024, with the sample received on 30 October 2024, and analysis completed on 1 November 2024. The results confirm a nearly accurate dosing, with only a slight deviation. However, continued scrutiny of manufacturer-submitted samples remains essential to ensure consistency across different batches. Independent third-party testing is recommended for further validation. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Olympian Pharmaceutical
- Product Name: Injectable Dbol 50mg
- Active Ingredient: Methandienone
- Batch Number: 0069
- Expiration Date: Not provided
- Delivery Method: Injectable
Sample Acquisition and Testing
- Task Number: #51794
- Testing Ordered: 24 October 2024
- Sample Received: 30 October 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Olympian Pharmaceutical (Manufacturer)
- Analysis Paid For By: Olympian Pharmaceutical (Manufacturer)
Testing Results
- Specification: 50 mg/ml (as stated on the label)
- Measured Concentration: 49.11 mg/ml
- Accuracy: 98.22% (1.78% below the label claim)
Verification Details
Verification URL: https://janoshik.com/tests/51794_192CL58RQFGQ
Evaluation of Manufacturer-Submitted Testing
This analysis confirms that Injectable Dbol 50mg contains almost the exact Methandienone concentration as labeled, with only a slight underdosing of 1.78%. Although this deviation is minor, continued monitoring and independent third-party testing are recommended to ensure consistency across multiple batches. While Janoshik Analytical is known for its rigorous testing and transparency, further validation through external sources would enhance confidence in these findings.
Conclusion
The findings confirm that Injectable Dbol 50mg is slightly underdosed, with a measured concentration of 49.11 mg/ml compared to the labeled 50 mg/ml. This small deviation is within an acceptable range; however, continued testing is necessary to maintain consistency in dosing. This report is provided as an educational resource to promote harm reduction and informed decision-making.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it still provides useful data when critically assessed alongside third-party or independent results. Readers are encouraged to interpret this information responsibly.
